Yasmin, Yasminelle and Yaz: drospirenone pills compared
Yasmin, Yasminelle and Yaz are combined contraceptive pills with the same two hormones: drospirenone, a progestogen, and ethinylestradiol, an oestrogen. They differ in the oestrogen dose and in how the pack is laid out, and that changes what you do after a missed tablet. This page compares the three, explains the risk of blood clots the doctor weighs up before prescribing, and lists the side effects given in the product information.
Three pills with the same two hormones
All three products are combined hormonal contraceptives: each active tablet contains 3 mg of drospirenone together with ethinylestradiol. Yasmin has 0.03 mg of ethinylestradiol per tablet, while Yasminelle and Yaz have 0.02 mg. Yasmin and Yasminelle are taken for 21 days followed by a 7-day break, and Yaz is taken every day from a 28-tablet pack in which the last 4 tablets contain no hormones.
In the Medicines Authority register, all three are classified as prescription-only medicines (POM), under marketing authorisations and several parallel import authorisations. Because the doses and the pack layouts differ, one pill is not swapped for another without the doctor. Combined contraception also comes as a vaginal ring and a patch, and all the methods are compared on our page about the contraceptive pill.
| Product | Hormones per active tablet | How the pack works | Authorisations (MMA) |
|---|---|---|---|
| Yasmin | Drospirenone 3 mg, ethinylestradiol 0.03 mg | 21 tablets, then 7 days without tablets | MA639/02801, PI770/21901A, PI908/16401B |
| Yasminelle | Drospirenone 3 mg, ethinylestradiol 0.02 mg | 21 tablets, then 7 days without tablets | MA639/00101, PI908/16601A, PI770/22001A |
| Yaz | Drospirenone 3 mg, ethinylestradiol 0.02 mg | 24 active tablets, then 4 tablets without hormones, no break | MA639/00601, PI1438/06801B |
Yasmin: 21 tablets and a 7-day break
You take one Yasmin tablet every day at about the same time, in the order shown on the blister, for 21 days, then stop for 7 days. A withdrawal bleed usually starts on day 2 or 3 of the break and may not have finished when you start the next pack, as the summary of product characteristics (SmPC, section 4.2) describes. The next pack starts after the 7 tablet-free days.
If you are less than 12 hours late with a tablet, protection is not reduced: take it when you remember and the next one at the usual time. If you are more than 12 hours late, protection may be reduced and the missed-tablet rules for your week of the pack apply (see the section on missed tablets below).
Yasminelle: the same progestogen with less oestrogen
Yasminelle contains the same 3 mg of drospirenone as Yasmin, but 0.02 mg of ethinylestradiol instead of 0.03 mg. The pack works in the same way: 21 tablets, then a 7-day break with a withdrawal bleed. The 12-hour limit for a late tablet is the same as for Yasmin, according to the Yasminelle SmPC (section 4.2).
The SmPCs of Yasmin, Yasminelle and Yaz give the same estimate of the risk of clots in veins for pills containing drospirenone (section 4.4), described in the section on blood clots below.
Yaz: 24 active tablets and 4 inactive ones
The Yaz pill has the same hormones and doses as Yasminelle, but a different pack. You take a tablet every day for 28 days without a break: 24 tablets contain the hormones and the last 4 do not. The next pack starts the day after the last tablet of the previous one, and the withdrawal bleed usually begins on day 2 or 3 of the inactive tablets (Yaz SmPC, section 4.2).
Two rules differ from Yasmin and Yasminelle. The limit for a late active tablet is 24 hours rather than 12, and a missed inactive tablet from the last row can be disregarded, although it should be thrown away so that the hormone-free phase is not made longer by mistake. The missed-tablet advice for Yaz is grouped by days 1 to 7, 8 to 14 and 15 to 24 of the pack.
How drospirenone pills prevent pregnancy
According to the SmPC, the contraceptive effect rests on several factors, the most important being that ovulation is stopped and the lining of the womb changes (section 5.1). Drospirenone also has anti-androgenic and mild anti-mineralocorticoid properties, which gives it a profile close to the natural hormone progesterone.
Protection depends on taking the tablets as directed. The SmPC names missed tablets, vomiting or diarrhoea, and some other medicines as reasons the pill may work less well (section 4.4). Hormonal contraceptives do not protect against HIV or other sexually transmitted infections; condoms can be used together with the pill for that.
Starting a drospirenone pill or switching to one
If you have not used hormonal contraception in the past month, you start on the first day of your period. If you are changing from another combined pill, you start preferably the day after its last active tablet, and at the latest the day after its usual break or inactive tablets. From a vaginal ring or a patch, you start preferably on the day it is removed, and at the latest when the next one would have been due (SmPC, section 4.2).
From a progestogen-only pill you can switch on any day, and from an implant or a hormonal coil on the day it is removed; in these cases you also use a barrier method such as a condom for the first 7 days of tablets. After giving birth, the SmPC advises starting on day 21 to 28, with a barrier method for the first 7 days if you start later.
Missed tablets, vomiting and diarrhoea
Two basic rules come from the SmPC: tablets must never be stopped for longer than 7 days, and 7 days of uninterrupted active tablets are needed for reliable protection. If you missed a tablet in the first week of the pack and had sex in the 7 days before, the possibility of pregnancy should be considered, and you use a condom for the next 7 days. Later in the pack the advice depends on how many tablets you missed and on whether you took them correctly in the week before.
Severe vomiting or diarrhoea can stop the hormones being fully absorbed, and the SmPC then advises extra contraception. If you vomit within 3 to 4 hours of a tablet, take a replacement as soon as possible; if more than 12 hours pass, or 24 hours with Yaz, the missed-tablet rules apply. Follow the leaflet for the product you actually hold. Our guide to a missed contraceptive pill explains the steps, and emergency contraception after a risk is a separate question, where timing matters. Emergency contraception is not part of our Contraception service.
The risk of blood clots
Every combined hormonal contraceptive increases the risk of a clot in a vein (venous thromboembolism, VTE) compared with not using one. The SmPC estimates that about 2 in 10,000 women who do not use one and are not pregnant develop a VTE in a year, between 9 and 12 in 10,000 women using a pill with drospirenone, and about 6 in 10,000 with a pill containing levonorgestrel (section 4.4). All these numbers are lower than the number expected during pregnancy or after giving birth, and VTE can be fatal in 1 to 2% of cases.
Risk peaks during the first year on any combined method, and there is some evidence that it climbs again after a restart following a gap of 4 weeks or longer. It increases with obesity (BMI over 30), age, particularly over 35, a sibling or parent who had a clot at a relatively young age, major surgery, an operation on the legs or pelvis, or a long period of immobility, and the 6 weeks after giving birth. Long flights of more than 4 hours can add to the risk, especially with other risk factors.
Smoking, high blood pressure, migraine, diabetes and age over 35 raise the risk of clots in arteries, such as heart attack and stroke. The SmPC advises women who want to use a combined pill not to smoke, and women over 35 who continue to smoke to use a different method. Before planned surgery, the SmPC advises stopping the pill at least four weeks in advance and restarting two weeks after you are fully mobile again.
Who should not take Yasmin, Yasminelle or Yaz
The SmPC lists these contraindications (section 4.3). If one of them appears for the first time while you take the pill, it is stopped at once. Your blood pressure, your personal and family history and pregnancy are checked before you start (section 4.4).
- A clot in a vein now or in the past, such as deep vein thrombosis or pulmonary embolism, or a known inherited or acquired tendency to clotting.
- Major surgery with prolonged immobilisation, or several risk factors that together make clots likely.
- A heart attack, angina, stroke or transient ischaemic attack, now or in the past, or a known tendency to clots in arteries.
- Migraine with focal neurological symptoms (aura).
- Diabetes with damage to blood vessels, severe high blood pressure or a severe disorder of blood fats.
- Severe liver disease, unless liver tests have returned to normal, or a liver tumour now or in the past.
- Severe kidney insufficiency or acute kidney failure.
- Cancer that depends on sex hormones, known or suspected, for example of the breast or genital organs.
- Vaginal bleeding that has not been diagnosed.
- Use of the hepatitis C medicines ombitasvir/paritaprevir/ritonavir with dasabuvir, glecaprevir/pibrentasvir or sofosbuvir/velpatasvir/voxilaprevir.
Warning signs that need urgent help
If you notice any of the signs below, the SmPC advises seeking urgent medical attention and telling the healthcare professional that you take a combined pill (section 4.4). In an emergency, call 112. A new migraine, or migraine that becomes more frequent or more severe while you take the pill, is a reason to contact a doctor promptly: the SmPC notes that it may be an early warning of a stroke and may be a reason to stop the pill immediately.
- Swelling of one leg or foot, or along a vein in the leg, pain or tenderness in the leg, warmth or red or discoloured skin.
- Breathlessness or rapid breathing that starts suddenly for no clear reason, a sudden cough, possibly with blood, a sharp pain in the chest, feeling very light-headed, or a racing or irregular pulse.
- Sudden numbness or weakness of the face, arm or leg, especially on one side, sudden trouble speaking, seeing, walking or keeping your balance, or a sudden, severe or prolonged headache.
- Pain, pressure or heaviness in the chest, arm or below the breastbone, sometimes spreading to the back, jaw or stomach, with sweating, nausea or breathlessness.
- Blurred vision without pain, or loss of vision.
Mood changes and depression
The SmPC describes depressed mood and depression as well-known undesirable effects of hormonal contraceptives, and depressed mood is listed as common with Yasmin (sections 4.4 and 4.8). The SmPC also warns that depression can be serious and that it is a well-known risk factor for suicidal behaviour and suicide. Contact a doctor if your mood changes or you notice symptoms of depression, including in the first weeks after you start.
Thoughts of harming yourself need help at once. In an emergency, call 112. Supportline 179 (Appoġġ): 24/7, free from landlines and mobiles. Richmond Foundation helpline 1770: Monday to Friday 8 am to 8 pm, Saturday until 4 pm.
Medicines that interact with drospirenone pills
Some medicines speed up the breakdown of the hormones and can lead to breakthrough bleeding or contraceptive failure. The SmPC names barbiturates, bosentan, carbamazepine, phenytoin, primidone, rifampicin, the HIV medicines ritonavir, nevirapine and efavirenz, possibly felbamate, griseofulvin, oxcarbazepine and topiramate, and St John's wort (section 4.5). With a short course of one of these, a barrier method is used during the treatment and for 28 days after it; with long-term treatment, another reliable non-hormonal method is recommended.
The pill can also change the levels of other medicines: ciclosporin may rise and lamotrigine may fall. Because drospirenone has a potassium-sparing effect, the SmPC advises a potassium blood test in the first cycle if you take potassium-sparing diuretics or aldosterone antagonists, and in kidney impairment with potassium in the upper range. List everything you take for the doctor, herbal remedies included.
Side effects in the summary of product characteristics
The table shows the side effects reported with Yasmin and their frequency in the SmPC (section 4.8). Irregular bleeding or spotting is common in the first months; the SmPC considers it meaningful to assess only after about three cycles, and bleeding that persists or starts after regular cycles needs to be investigated.
Current users of combined pills have a slightly increased risk of being diagnosed with breast cancer, which gradually disappears in the 10 years after stopping; because breast cancer is rare under 40, the number of extra cases is small. Benign liver tumours have been reported rarely. Some women do not have a withdrawal bleed in the break; if tablets were taken correctly, pregnancy is unlikely, but if they were not, or two bleeds are missed, pregnancy must be ruled out before you continue.
| Frequency | Side effects listed for Yasmin |
|---|---|
| Common (up to 1 in 10) | Low mood, headache, migraine, feeling sick, period problems, bleeding between periods, sore or tender breasts, vaginal discharge, vaginal yeast infection (thrush) |
| Uncommon (up to 1 in 100) | Higher or lower libido, raised or low blood pressure, being sick, diarrhoea, acne, eczema, itchy skin, hair loss, larger breasts, vaginal infection, fluid retention, weight going up or down |
| Rare (up to 1 in 1000) | Allergic reactions, asthma, reduced hearing, clots in veins or arteries, erythema nodosum, erythema multiforme, discharge from the breast |
Pregnancy, breast-feeding and after giving birth
These pills are not used in pregnancy. If you become pregnant while taking one, the SmPC says it is stopped at once (section 4.6). Large studies have not shown an increased risk of birth defects in children of women who took a combined pill before pregnancy or by mistake during pregnancy.
Combined pills may reduce the amount of breast milk and change its composition, so the SmPC generally does not recommend them until you have completely weaned your baby. After giving birth, the higher risk of clots is taken into account when the pill is restarted.
How a request for a drospirenone pill is assessed
You fill in a medical questionnaire about the medicine, your health and other medicines you take, and the doctor reviews it in writing, whether you are starting a pill, continuing one or changing from another method. The doctor weighs your risk of clots, your blood pressure and your history, may ask for a recent blood pressure reading, may suggest a different method or may decline. If the doctor has questions, they ask them in writing in the chat in your account, and you get an email to let you know. There is no video call, no phone call and no live chat.
For some conditions, and in some individual cases, it is advisable to see a doctor in person; the doctor may recommend this. New symptoms, above all the warning signs listed above, need a doctor who can examine you.
If the doctor issues a prescription, you receive it as a PDF by email. You print it and bring it on paper to a pharmacy in Malta together with photo identification. Your prescription is issued in the standard EU cross-border format set out in Directive 2012/52/EU. A pharmacy in Malta may dispense it; the decision rests with the pharmacist. Take the prescription to a pharmacy within six months of the date on it; a prescription for an antibiotic cannot be dispensed more than ten days after its date of issue.
What does it cost?
The button on this page shows the fee for the doctor's review under our Contraception service. The pill is paid for separately at the pharmacy, which sets the price of each pack. It is not an ePrescription and does not appear in myHealth; it is outside POYC and the Government Formulary List, and you pay for the medicine at the pharmacy in full.
The fee covers the medical consultation, not the issuing of a document. If the doctor declines on medical or legal grounds, we refund the fee. If the doctor asks you for documents, you have at least 7 days to send them in and we send you a reminder; if you ask us, we agree a longer deadline. If the case still cannot be completed, we close the request, let you know and refund the fee in full.
Who reviews your request?
Your request is reviewed by Damian Wojno, a doctor registered with the Polish Medical Chamber, licence no. 3211301. The doctor is not registered with the Medical Council of Malta.
Is Yasmin prescription-only in Malta?
Every Yasmin, Yasminelle and Yaz authorisation in the Medicines Authority register is classified as a prescription-only medicine (POM), and so are all 13 authorised products in that register that contain drospirenone. Before a combined pill is started, the doctor weighs your risk of clots, your blood pressure and the other medicines you take.
What is the difference between Yasmin and Yaz?
Yasmin has 0.03 mg of ethinylestradiol per tablet and is taken for 21 days with a 7-day break. Yaz has 0.02 mg and is taken every day from a 28-tablet pack, in which the last 4 tablets contain no hormones. Both contain 3 mg of drospirenone, and the late-tablet limit is 12 hours for Yasmin and 24 hours for Yaz.
Is Yasminelle the same as Yaz?
The hormones and doses are the same, 3 mg of drospirenone and 0.02 mg of ethinylestradiol, but the packs differ. Yasminelle has 21 tablets followed by a 7-day break, while Yaz has 24 active tablets followed by 4 without hormones and no break. The missed-tablet rules are different, so follow the leaflet of the product you take.
What should I do if I miss a Yasmin or Yaz pill?
If you are less than 12 hours late with Yasmin or Yasminelle, or less than 24 hours with an active Yaz tablet, take it when you remember and carry on as usual. If you are later than that, protection may be reduced, and the steps depend on the week of the pack; use a condom where the leaflet says so and consider whether emergency contraception is needed.
Do drospirenone pills carry a higher risk of blood clots?
The SmPC estimates that 9 to 12 in 10,000 women using a pill with drospirenone develop a clot in a vein each year, compared with about 6 in 10,000 with a levonorgestrel pill and about 2 in 10,000 women who use no hormonal contraception and are not pregnant. The risk is highest in the first year of use.
Does Yasmin protect against sexually transmitted infections?
No. Hormonal contraceptives do not protect against HIV or other sexually transmitted infections. Condoms reduce that risk and can be used together with the pill.
When does Yasmin start to protect against pregnancy?
If you start on the first day of your period and have not used hormonal contraception in the past month, the SmPC does not ask for extra protection. If you switch from a progestogen-only pill, an implant or a hormonal coil, or start later than day 21 to 28 after giving birth, use a condom for the first 7 days of tablets.
- Medicines Authority: Yasmin 0.03 mg/3 mg film-coated tablets (MA639/02801), with summary of product characteristics and package leaflet
- Medicines Authority: Yasmin 0.03 mg/3 mg film-coated tablets, parallel import (PI770/21901A)
- Medicines Authority: Yasminelle 0.02 mg/3 mg film-coated tablets (MA639/00101)
- Medicines Authority: Yaz 0.02 mg/3 mg film-coated tablets (MA639/00601)
- Medicines Authority: prescription-only and non-prescription medicines
- Medicines Act (Cap. 458), Article 81 (legislation.mt)
- Prescription and Dispensing Requirements Rules (S.L. 458.49), rule 4 (legislation.mt)
- Commission Implementing Directive 2012/52/EU on the recognition of medical prescriptions issued in another Member State (EUR-Lex)